Susquehanna International Group, LLP Inmune Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 23,495 shares of INMB stock, worth $175,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,495
Previous 213,400
88.99%
Holding current value
$175,272
Previous $1.15 Million
90.52%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding INMB
# of Institutions
80Shares Held
7.04MCall Options Held
202KPut Options Held
42.9K-
Black Rock Inc. New York, NY813KShares$6.06 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$6.06 Million1.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA738KShares$5.51 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.45 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$3.55 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $134M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...